CTI Biopharma Corp - ESG Rating & Company Profile powered by AI
Other corporations in the scoring industry group for CTI Biopharma Corp are shown. Browse to the end of this webpage for potential risks for CTI Biopharma Corp based on industry, location and marketcap. Full ESG assessment of CTI Biopharma Corp are accessed by logging in.
CTI Biopharma Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.6; made up of an environmental score of 2.7, social score of 3.2 and governance score of 2.0.
2.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1437 | Valenta Farmatsevtika AO | 2.7 | Medium |
| 1437 | Wockhardt Bio AG | 2.7 | Medium |
| 1481 | CTI Biopharma Corp | 2.6 | Medium |
| 1481 | Cannara Biotech Inc | 2.6 | Medium |
| 1481 | Acacia Pharma Group PLC | 2.6 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does CTI Biopharma Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes CTI Biopharma Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes CTI Biopharma Corp report the average age of the workforce?
Sign up for free to unlockDoes CTI Biopharma Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes CTI Biopharma Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes CTI Biopharma Corp disclose cybersecurity risks?
Sign up for free to unlockDoes CTI Biopharma Corp offer flexible work?
Sign up for free to unlockDoes CTI Biopharma Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes CTI Biopharma Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes CTI Biopharma Corp conduct supply chain audits?
Sign up for free to unlockDoes CTI Biopharma Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes CTI Biopharma Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes CTI Biopharma Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes CTI Biopharma Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes CTI Biopharma Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes CTI Biopharma Corp disclose water use targets?
Sign up for free to unlockDoes CTI Biopharma Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid CTI Biopharma Corp have a product recall in the last two years?
Sign up for free to unlockDoes CTI Biopharma Corp disclose incidents of discrimination?
Sign up for free to unlockDoes CTI Biopharma Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas CTI Biopharma Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes CTI Biopharma Corp disclose parental leave metrics?
Sign up for free to unlockDoes CTI Biopharma Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes CTI Biopharma Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes CTI Biopharma Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes CTI Biopharma Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes CTI Biopharma Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes CTI Biopharma Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs CTI Biopharma Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes CTI Biopharma Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes CTI Biopharma Corp disclose its waste policy?
Sign up for free to unlockDoes CTI Biopharma Corp report according to TCFD requirements?
Sign up for free to unlockDoes CTI Biopharma Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes CTI Biopharma Corp disclose energy use targets?
Sign up for free to unlockDoes CTI Biopharma Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes CTI Biopharma Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for CTI Biopharma Corp
These potential risks are based on the size, segment and geographies of the company.
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.